Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease

Background: Metformin has been introduced as a neuroprotective agent in recent years. Here we evaluate the therapeutic effects of metformin in sporadic mouse model of Alzheimer's disease (SAD). Methods: AD was induced by streptozotocin (STZ, 0.5 mg/kg) on days 1 and 3. Metformin (MET, 200 mg/kg...

Full description

Bibliographic Details
Main Authors: Saghar Rabieipoor, Meysam Zare, Miren Ettcheto, Antoni Camins, Mohammad Javan
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023050818